Joseph T. Hull

Joseph T. Hull, PhD, is an experienced clinical development leader currently serving as the Director of Clinical Development at Supernus Pharmaceuticals, Inc., where involvement spans roles from Associate Director to Director since September 2018. Prior to this, Joseph held the position of Associate Director, Clinical Development Scientist at Vanda Pharmaceuticals from November 2015 to September 2018. Joseph's extensive research background includes over 17 years at Brigham and Women's Hospital, contributing as a Research Scientist in the Division of Sleep and Circadian Disorders, focusing on human circadian rhythms and sleep-wake physiology. Educational credentials include a PhD in Health and Medical Science from the University of Surrey and a Bachelor of Science in Psychology from Northeastern University, alongside notable fellowships and research roles at Harvard Medical School.